Topline data were announced from a phase 3 trial evaluating ceralasertib plus Imfinzi in patients with locally advanced or metastatic NSCLC.

Black and Hispanic/Latino patients with food allergies are less apt to recognize anaphylaxis and have more limited EAI access than White patients.

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

Most people in the United States are happy with their health insurance, but many still struggle with denied claims, delays and rising costs.

Scrolling is still a big part of daily life for American teenagers, despite mounting worries about screen time and mental health.

Severe airflow obstruction was prevalent in children and adults with asthma, especially those who were extremely preterm or small for gestational age.

Nearly 1 in 4 Americans believe the US health care system is in crisis, and high costs are the top reason why.